Mecobalamin Tablets Market Drivers: Rising Prevalence of Vitamin B12 Deficiency and Neurological Disorders The Mecobalamin Tablets Market drivers are strongly influencing the consistent growth of the industry, primarily due to the rising global incidence of vitamin B12 deficiency and neurological disorders. Mecobalamin, being the biologically active form of vitamin B12, is widely utilized in treating conditions such as peripheral neuropathy, diabetic neuropathy, and megaloblastic anemia. As healthcare awareness continues to improve, especially in developing regions, the demand for effective and fast-acting vitamin B12 therapies is increasing. This growing clinical reliance on mecobalamin formulations is expected to support a steady market expansion at a CAGR of around 7% during the forecast period from 2026 to 2034. Read More - https://www.theinsightpartners.com/reports/mecobalamin-tablets-market